These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26159859)

  • 41. Primary CNS lymphoma: a clinician's guide.
    Schäfer N; Glas M; Herrlinger U
    Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years.
    Ferreri AJ; Ciceri F; Brandes AA; Montanari M; Balzarotti M; Spina M; Ilariucci F; Zaja F; Stelitano C; Bobbio F; Corazzelli G; Baldini L; Reni M
    Neurology; 2014 Apr; 82(15):1370-3. PubMed ID: 24634458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Primary central nervous system lymphoma].
    Royer-Perron L; Hoang-Xuan K; Houillier C
    Rev Prat; 2016 Apr; 66(4):419-422. PubMed ID: 30512707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC; Roos DE; Liew KH; Trotter GE; Barton MB; Walker QJ; Poulsen MG; Olver IN
    Med J Aust; 1996 Oct; 165(8):424-7. PubMed ID: 8913243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
    Moise L; Matta C; Hanna C; Pilorge S; Fermé C; Durrbach A; Ribrag V
    Leuk Lymphoma; 2011 Mar; 52(3):521-4. PubMed ID: 21133726
    [No Abstract]   [Full Text] [Related]  

  • 46. Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
    Harjama L; Kuitunen H; Turpeenniemi-Hujanen T; Haapasaari KM; Leppä S; Mannisto S; Karjalainen-Lindsberg ML; Lehtinen T; Eray M; Vornanen M; Haapasalo H; Soini Y; Jantunen E; Nousiainen T; Vasala K; Kuittinen O
    Acta Oncol; 2015 Jun; 54(6):939-43. PubMed ID: 25761092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
    Pels H; Schmidt-Wolf IG; Glasmacher A; Schulz H; Engert A; Diehl V; Zellner A; Schackert G; Reichmann H; Kroschinsky F; Vogt-Schaden M; Egerer G; Bode U; Schaller C; Deckert M; Fimmers R; Helmstaedter C; Atasoy A; Klockgether T; Schlegel U
    J Clin Oncol; 2003 Dec; 21(24):4489-95. PubMed ID: 14597744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Updates on Primary Central Nervous System Lymphoma.
    Schaff LR; Grommes C
    Curr Oncol Rep; 2018 Feb; 20(2):11. PubMed ID: 29492682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Curative Efficacy of High Dose MTX Combined with Rituxan for Treatment Primary CNS Lymphoma].
    Mou K; Gu WW; Gu CH; Qi JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1406-1409. PubMed ID: 29070115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
    Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
    Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
    Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
    Korfel A; Thiel E; Martus P; Möhle R; Griesinger F; Rauch M; Röth A; Hertenstein B; Fischer T; Hundsberger T; Mergenthaler HG; Junghanß C; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Roth P; Bamberg M; Pietsch T; Weller M
    Neurology; 2015 Mar; 84(12):1242-8. PubMed ID: 25716362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary central nervous system lymphoma: is there still a role for radiotherapy?
    Graber JJ; Omuro A
    Curr Opin Neurol; 2011 Dec; 24(6):633-40. PubMed ID: 21968551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.
    Ferreri AJ; Verona C; Politi LS; Chiara A; Perna L; Villa E; Reni M
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):169-75. PubMed ID: 20584577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.
    Ferreri AJ; Reni M; Villa E
    Ann Oncol; 2000 Aug; 11(8):927-37. PubMed ID: 11038028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].
    Shiota Y; Dobashi N; Ito Y; Hosoba R; Yamauchi H; Ishii H; Nakano A; Fukushima R; Ohba R; Yahagi Y; Usui N; Yano S
    Rinsho Ketsueki; 2019; 60(2):87-92. PubMed ID: 30842385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of primary central nervous system lymphoma in the elderly.
    Hoang-Xuan K; Chinot OL; Taillandier L
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):53-7. PubMed ID: 14765387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
    Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S; Schorb E; Zucca E; Hemkens LG; Schandelmaier S; Kasenda B
    Hematol Oncol; 2019 Dec; 37(5):548-557. PubMed ID: 31418878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.